RNA editing of the human serotonin 5-HT2C receptor: Alterations in suicide and implications for serotonergic pharmacotherapy

Neuropsychopharmacology

Volumn 24, Issue 5, 2001, Pages 478-491

  Niswender, Colleen M ^a,b,e   Herrick Davis, Katherine ^c   Dilley, Ginney E ^d   Meltzer, Herbert Y ^a,b   Overholser, James C ^d   Stockmeier, Craig A ^d,f   Emeson, Ronald B ^a,b   Sanders Bush, Elaine ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c ALBANY MEDICAL COLLEGE   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

5 HT2C receptor; Clozapine; Depression; LSD; RNA editing; Schizophrenia; Serotonin; Suicide

Indexed keywords

ADENOSINE; CHLORPROMAZINE; CLOZAPINE; GUANINE NUCLEOTIDE BINDING PROTEIN; INOSINE; ISOPROTEIN; LOXAPINE; LYSERGIDE; NEUROLEPTIC AGENT; PSYCHEDELIC AGENT; RNA; SEROTONIN 2C RECEPTOR; SEROTONIN AGONIST; THIORIDAZINE;

ADULT; AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; DRUG RECEPTOR BINDING; FEMALE; HUMAN; HUMAN TISSUE; MALE; PREFRONTAL CORTEX; PRIORITY JOURNAL; RECEPTOR AFFINITY; RNA EDITING; SCHIZOPHRENIA; SUICIDE;

ADULT; AMINO ACID SEQUENCE; ANIMALS; ANTIPSYCHOTIC AGENTS; COS CELLS; DEPRESSIVE DISORDER; FEMALE; HUMANS; LYSERGIC ACID DIETHYLAMIDE; MALE; MIDDLE AGED; PREFRONTAL CORTEX; PROTEIN ISOFORMS; RECEPTOR, SEROTONIN, 5-HT2C; RECEPTORS, SEROTONIN; RNA EDITING; RNA, MESSENGER; SCHIZOPHRENIA; SEROTONIN; SEROTONIN AGONISTS; SUICIDE;

EID: 0035085519     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(00)00223-2     Document Type: Article

References (42)

1. 2A receptor. Ser3.36(159) provides a second interaction site for the protonated amine of serotonin but not of lysergic acid diethylamide or bufotenin
2. Effects of second intracellular loop mutations on signal transduction, internalization of the gonadotropin-releasing hormone receptor
3. Functional microdomains in G-protein-coupled receptors. The conserved arginine-cage motif in the gonadotropin-releasing hormone receptor
4. 2C receptors reveal novel inverse agonist activity of receptor ligands
5. 2C receptor systems
6. Mapping of single amino acid residues required for selective activation of Gq/11 by the m3 muscarinic acetylcholine receptor
7. Regulation of serotonin-2C receptor G-protein coupling by RNA editing
8. 1C receptor agonist
9. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
10. 2C receptors
11. A diagnostic interview: The schedule for affective disorders and schizophrenia
12. Messenger RNA editing of the human serotonin 5-HT2C receptor
13. Does loxapine have "atypical" properties? Clinical evidence
14. 2C Receptor RNA editing alters receptor basal activity: Implications for serotonergic signal transduction
15. 2C receptor
16. 2C receptor polymorphisms and psychopathology in late onset Alzheimer's disease
17. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin)
18. Selective increases in phosphoinositide signaling activity and G protein levels in postmortem brain from subjects with schizophrenia or alcohol dependence
19. 2C receptor antagonist
20. 2C receptor gene (HTR2C)
21. 2C receptor agonists: Pharmacological characteristics and therapeutic potential
22. Low-dose loxapine in the treatment of schizophrenia: Is it more effective and more "atypical" than standard-dose loxapine?
23. Relapse following clozapine withdrawal: Effect of neuroleptic drugs and cyproheptadine
24. The ratios of serotonin2 and dopamine2 affinities differentiate atypical and typical antipsychotic drugs
25. Inverse agonism: Pharmacological curiosity or potential therapeutic strategy?
26. 2C receptor agonists exhibit antidepressant-like properties in the anhedonia model of depression in rats
27. Hydrophobic amino acid in the i2 loop plays a key role in receptor-G protein coupling
28. 2C receptors expressed in the human neuroblastoma cell line SH-SY5Y: Comparative stimulation by hallucinogenic drugs
29. RNA editing of the human serotonin 5-hydroxytryptamine 2C receptor silences constitutive activity
30. The role of serotonin in schizophrenia
31. Cloning of the human serotonin 5-HT2 and 5-HT1C receptor subtypes
32. A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model
33. 2C receptor gene
34. RNA editing
35. Serotonin receptors in suicide victims with major depression
36. The thrombin receptor second cytoplasmic loop confers coupling to Gq-like G proteins in chimeric receptors. Additional evidence for a common transmembrane signaling and G protein coupling mechanism in G protein-coupled receptors
37. Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment
38. Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis
39. Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action
40. Reciprocal binding properties of 5-hydroxytryptamine type 2C receptor agonists and inverse agonists
41. The human serotonin 5-HT-2C receptor complete cDNA, genomic structure and alternatively spliced variant